Literature DB >> 25430680

Restarting oral anticoagulants after intracerebral hemorrhage: pros.

George Ntaios1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25430680     DOI： 10.1007/s11739-014-1160-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  20 in total

1.  Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage.

Authors:  R D Bailey; R G Hart; O Benavente; L A Pearce
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

2.  Edoxaban versus warfarin for venous thromboembolism.

Authors:  Harry R Büller
Journal:  N Engl J Med       Date:  2014-01-02       Impact factor: 91.245

3.  Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study.

Authors:  Daniela Poli; Emilia Antonucci; Francesco Dentali; Nicoletta Erba; Sophie Testa; Eros Tiraferri; Gualtiero Palareti
Journal:  Neurology       Date:  2014-02-21       Impact factor: 9.910

4.  Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study.

Authors:  Derek Yung; Moira K Kapral; Eriola Asllani; Jiming Fang; Douglas S Lee
Journal:  Can J Cardiol       Date:  2011-12-07       Impact factor: 5.223

5.  Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage.

Authors:  Daniel O Claassen; Noojan Kazemi; Alexander Y Zubkov; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-10

6.  Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Sebastian Schellong; Henry Eriksson; David Baanstra; Anne Mathilde Kvamme; Jeffrey Friedman; Patrick Mismetti; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

Review 7.  Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials.

Authors:  George Ntaios; Vasileios Papavasileiou; Hans-Christoph Diener; Konstantinos Makaritsis; Patrik Michel
Journal:  Stroke       Date:  2012-11-13       Impact factor: 7.914

8.  Apixaban for extended treatment of venous thromboembolism.

Authors:  Giancarlo Agnelli; Harry R Buller; Alexander Cohen; Madelyn Curto; Alexander S Gallus; Margot Johnson; Anthony Porcari; Gary E Raskob; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2012-12-08       Impact factor: 91.245

9.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

10.  European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.

Authors:  Thorsten Steiner; Rustam Al-Shahi Salman; Ronnie Beer; Hanne Christensen; Charlotte Cordonnier; Laszlo Csiba; Michael Forsting; Sagi Harnof; Catharina J M Klijn; Derk Krieger; A David Mendelow; Carlos Molina; Joan Montaner; Karsten Overgaard; Jesper Petersson; Risto O Roine; Erich Schmutzhard; Karsten Schwerdtfeger; Christian Stapf; Turgut Tatlisumak; Brenda M Thomas; Danilo Toni; Andreas Unterberg; Markus Wagner
Journal:  Int J Stroke       Date:  2014-08-24       Impact factor: 5.266
View more
  4 in total

1.  Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration-authors' reply.

Authors:  George Ntaios; Simona Sacco
Journal:  Intern Emerg Med       Date:  2015-02-24       Impact factor: 3.397

2.  Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration.

Authors:  Maurizio Balestrino; Chiara Bruno; Cinzia Finocchi; Carlo Gandolfo
Journal:  Intern Emerg Med       Date:  2015-02-25       Impact factor: 3.397

3.  Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage.

Authors:  Simone Birocchi; Gian Marco Podda
Journal:  Intern Emerg Med       Date:  2016-11-04       Impact factor: 3.397

Review 4.  Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?

Authors:  Emanuel Raschi; Matteo Bianchin; Cecilia Fantoni; Walter Ageno; Fabrizio De Ponti; Roberto De Ponti
Journal:  Intern Emerg Med       Date:  2017-08-07       Impact factor: 3.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.